Search Results - "PRACCHIA, Luis F"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
  2. 2
  3. 3

    18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin lymphoma by Cerci, Juliano J, Pracchia, Luís F, Linardi, Camila C G, Pitella, Felipe A, Delbeke, Dominique, Izaki, Marisa, Trindade, Evelinda, Soares, Jr, José, Buccheri, Valeria, Meneghetti, José C

    Published in The Journal of nuclear medicine (1978) (01-09-2010)
    “…Our objective was to assess the prognostic value of (18)F-FDG PET after 2 cycles of chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine…”
    Get full text
    Journal Article
  4. 4

    2-[18F]-fluoro-2-desoxy-D-glucose positron emission tomography initial staging impacts on survival in Hodgkin lymphoma by Cerci, Juliano J, Linardi, Camila C G, Pracchia, Luís F, Junior, José Soares, Trindade, Evelinda, Delbeke, Dominique, Cerci, Rodrigo J, Carr, Robert, Meneghetti, José C, Buccheri, Valeria

    Published in World journal of radiology (28-12-2013)
    “…AIM:To assess the prognostic value and risk classification improvement of metabolic staging(MS)with Initial2-[18F]-fluoro-2-desoxy-D-glucose positron emission…”
    Get full text
    Journal Article
  5. 5

    Bone Marrow Biopsy for the Staging of Diffuse Large B-Cell Lymphoma: Is It Necessary Bilateral Trephine Biopsy? by Bellesso, Marcelo, Velasques, Rodrigo D., Pracchia, Luis F., Beitler, Beatriz, Aldred, Vera L., Chamone, Dalton, Kutner, Jose M., Pereira, Juliana

    Published in Blood (16-11-2007)
    “…In this retrospective analysis we study the usefulness of bilateral rather than unilateral iliac trephine biopsies in demonstrating Diffuse Large B-Cell…”
    Get full text
    Journal Article
  6. 6

    Modified Magrath IVAC Regimen as Second-Line Therapy for Relapsed and Refractory Aggressive Non-Hodgkin Lymphoma in Developing Countries: The Experience of a Single Center in Brazil by Pracchia, Luis F., Pereira, Juliana, Belesso, Marcelo, Beitler, Beatriz, Chamone, Dalton A.

    Published in Blood (16-11-2004)
    “…In this retrospective study we described the response and toxicity of a modified Magrath IVAC (mIVAC) regimen in 25 patients with refractory/relapsed…”
    Get full text
    Journal Article
  7. 7

    sup 18^F-FDG PET After 2 Cycles of ABVD Predicts Event-Free Survival in Early and Advanced Hodgkin Lymphoma by Cerci, Juliano J, Pracchia, Luís F, Linardi, Camila C G, Pitella, Felipe A, Delbeke, Dominique, Izaki, Marisa, Trindade, Evelinda, Junior, José Soares, Buccheri, Valeria, Meneghetti, José C

    Published in The Journal of nuclear medicine (1978) (01-09-2010)
    “…Our objective was to assess the prognostic value of ^sup 18^F-FDG PET after 2 cycles of chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Linfoma não Hodgkin gástrico Gastric non-Hodgkin Lymphoma by Renata O. Costa, Abrahão E. Hallack Neto, Dalton A. F. Chamone, Vera Lúcia Aldred, Luis F. Pracchia, Juliana Pereira

    “…Os linfomas extralinfonodais representam aproximadamente 1/3 de todos os linfomas não Hodgkin (LNH) e, embora possam ter início em qualquer tecido, mais…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Tratamento do linfoma de Hodgkin após falha do transplante autólogo Treatment of Hodgkin's lymphoma after failure of autologous stem cell transplant by Fernanda M. Santos, Luís F. Pracchia, Camila G. C. Linardi, Valeria Buccheri

    “…O linfoma de Hodgkin (LH) é uma neoplasia do tecido linfóide de excelente prognóstico, porém, aproximadamente 15% dos pacientes em estádios precoces e 35% dos…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16